For participants without diabetes at baseline, the research demonstrated preventive effects on glucose metabolism
As other drug companies started to see the potential of these peptides, they started tweaking them like chemists playing with Legos
Notably, these pathological changes were alleviated in CypD-knockout mice
Key highlights Tirzepatide is the first dual GLP-1/GIP receptor agonist that offers stronger appetite suppression, improved glycemic control, and provides significantly greater weight loss than single receptor agonists such as semaglutide, liraglutide, and dulaglutide
In ischemic stroke, blood vessel blockage results in glucose and oxygen deficiency, which triggers several biological response pathways and ultimately leads to irreversible brain damage (Sharma et al., 2022)
Blood thinners (Warfarin, etc.) - May increase bruising at injection sites